Cox-2-inhibitor [Cyclo-oxygenase-2-inhibitors] and Chemotherapy in Non-Small Cell Lung Cancer. A Prospective Randomized Double-Blind Study.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Celecoxib (Primary)
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms CYCLUS
- 07 Jul 2009 Actual patient number (319) added as reported by ClinicalTrials.gov.
- 07 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Jul 2009 Planned end date changed from May 2010 to Sep 2010 as reported by ClinicalTrials.gov.